Immigrant patients less likely to report family history of cancer

Immigrants in the United States may be less likely to report a family history of cancer, which may lead to inadequate screening and cancer prevention strategies according to a new study.

Dr. Heather Orom of the Barbara Ann Karmanos Cancer Institute in Detroit and colleagues argue that as a result of being less likely to report a family history, family history may not be as strong a predictor of cancer risk in immigrant populations. The study is published in the January 15, 2008 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Cancer prevention guidelines recommend earlier and more frequent screening for individuals with a family history of certain cancers. Therefore, knowledge and timely reporting of cancer history can impact access to cancer prevention and screening services. Previous research has identified lower rates of reporting cancer family history among African Americans, Hispanics, and Asian Americans than among Whites in the U.S. However, the current study is the first to examine whether an individual's immigrant status, in conjunction with race/ethnicity, plays a role in this under-reporting.

Dr. Orom and co-investigators studied data from 5,010 respondents to the 2005 Health Information Trends Survey. After controlling for race/ethnicity, other sociodemographic variables, and cancer knowledge, foreign-born respondents were about one-third as likely to report a family history of cancer as US-born respondents. The authors found that those who were single, male, or without health coverage were also less likely to report a family history of cancer.

The low rate of cancer history reporting did not change as immigrants became more integrated into American culture with time. The authors suggest that this may be due to fewer opportunities to learn about family health histories afforded to immigrants due to separation from relatives, as well as cultural norms that inhibit family communication about cancer diagnoses.

The investigators conclude that information regarding family history of cancer may not be as accurate an indicator of risk for foreign-born patients as it is for US-born patients. Dr. Orom suggests, "that some immigrants might not have a family history of cancer even though they have a genetic disposition for cancer, in part, because they are from countries in which people are more likely to die at a relatively young age of causes other than cancer, and are not exposed to the same degree of behavioral and environmental risk for the disease. In addition, due to under-diagnosis of cancer in many immigrants' countries of origin, lack of awareness of familial risk, and communication barriers in families, foreign-born patients may not be aware of their true family history of cancer." The authors note that failing to take into account that immigrants may have genetic risk without family history could lead to insufficiencies in cancer screening and prevention for immigrants and ethnic minorities.

This study was also co-authored by Drs. Michele Cot?, Willie Underwood, and Ann Schwartz of the Barbara Anne Karmanos Institute and Hector Gonz?lez of Wayne State University.

Article: "Family History of Cancer: Is it an Accurate Indicator of Cancer Risk in the Immigrant Population?" Heather Orom, Michele L. Cot?, Hector Gonz?lez, Willie Underwood, III, and Ann G. Schwartz, CANCER; Published Online: December 10, 2007 (DOI: 10.1002/cncr.23173); Print Issue Date: January 15, 2008.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Rare genetic mutations in healthy women may be key to breast cancer origins